Shuren: ‘You Can’t Be Expecting Us To Just Sit Back’

In a wide-ranging speech at FDLI’s 2023 annual meeting, CDRH director Jeffrey Shuren pledged to move forward with regulatory action on lab-developed tests and sketched plans for improved regulation of medical apps.

Jeff Shuren

More from Regulation

More from Policy & Regulation